The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

A graphic of a purple and magenta Cas9 protein, which is a somewhat round, but uneven, ball, bound to a yellow and orange ...

A cancer cell begins to die, and for the first time, a researcher can watch the exact moment it happens. New fluorescent dyes ...

A new analytical method could improve how cancer treatments are designed - by allowing scientists to track, for the first time, exactly where inside a living cell a drug accumulates. Researchers from ...

Be amazed by a piano animation done perfectly, where every key, note, and movement aligns flawlessly with the music. This video showcases incredible technical skill and attention to detail, ...

Created by VML Health, Beat Off Cancer puts a cheeky twist on traditional public awareness messaging by leaning into the euphemistic language of self-love ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys and be excreted into urine, as reported by researchers at Science Tokyo.

Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies to target the alternative lengthening of telomeres (ALT) pathway in cancer cells. Telomeres are ...